Axsome Therapeutics Inc. (AXSM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Axsome Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$143.51
+0.92% today
Market cap
$7.4B
Overall quality
42/100
Kronos AI 30-day
+58.3%
8 of 8 simulated paths end higher
Axsome Therapeutics Inc. (AXSM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $7.4B. It trades at $143.51, up 0.92% today. Its overall quality score is 42 out of 100, ranked against the whole US market. 16 analysts' average target of $284.63 implies +98.3% from today's price. Kronos AI's 30-day forecast is +58.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $284.63 |
| Low – high | $238.00 – $380.00 |
| Analysts | 16 |
| Upside to average | +98.3% |
Kronos AI 30-day forecast
| Expected close | $225.10 (+58.3%) |
| Likely range | +52.5% … +68.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 18 |
| Solvency | 32 |
| Growth | 77 |
| Overall | 42 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.